Acambis
Trademark details
Acambis® is a registered trademark used for Pharmaceutical Preparations For Use In the Treatment of Infectious Diseases, Autoimmune Diseases, Cancer and Allergies For Human and Veterinarian Use Computer Hardware and Computer Aided Design Software For Chemical and Biochemical Applications, Molecule Design, Vaccine Design, Protease Inhibitor Design, and For Database Management In the Field of Chemical, Biochemical and Peptide Libraries and owned by Acambis Research Limited. Full trade mark registration details, registered images and more information below.
| Goods and/or Services: | Pharmaceutical Preparations For Use In the Treatment of Infectious Diseases, Autoimmune Diseases, Cancer and Allergies For Human and Veterinarian Use Computer Hardware and Computer Aided Design Software For Chemical and Biochemical Applications, Molecule Design, Vaccine Design, Protease Inhibitor Design, and For Database Management In the Field of Chemical, Biochemical and Peptide Libraries Medical Computer Hardware and Software For Database Management In the Medical Field Parts, Fittings For the Aforementioned Hardware and Software Sold Together With the Hardware and Software As Components Computer Software Tools, Namely, Software For General Purposes Database Management Scientific, Biotechnology and Pharmaceutical Research and Development For Others Drug Design, Research and Development For Others Computer Aided Drug Design For Others Development of Vaccines For Others |
| Serial Number: | 76173697 |
| Registration Number: | 2714984 |
| Filing Date: | Nov 30, 2000 |
|
Last Applicant(s)/ Owner(s) of Record | Acambis Research LimitedPeterhouse Technology Park |
| Related Products: | Pharmaceuticals, Electrical and Scientific Apparatus, Miscellaneous Services; Scientific and technological services, and research and design relating thereto; Industrial analysis and research services; Design and development of computer hardware and software; Legal services |
Suppliers
Total : 3 View more »
Acambis Research Ltd in Cambridge, Cambridgeshire, United Kingdom
Edit this Company edit this company Acambis Research Ltd 100 Fulbourn Rd Cambridge, Cambridgeshire...United Kingdom tel: +44 1223275300 http://www.acambis.com Description Commercial Physical Research, Nsk...
Acambis in Cambridge, Massachusetts, USA
... Acambis 38 Sidney Street Cambridge, Massachusetts 02139 USA http://www.acambis.com/default.asp?id=1218 Description A leading...
Web Sites
Total : 8 View more »
doi:10.1016/S0140-6736(06)68418-3
...clear how this pertains to the results of our study. Acambis’ culture medium was used in our study because its...George Killgore, L Clifford McDonald michel.warny@acambis.com Acambis, 38 Sidney Street, Cambridge, MA 02139, USA...
The Lancet Infectious Diseases : Volume 1, Number 0, 1 April 2001
...smallpox attack Dorothy Bonn Preview | Full Text | PDF Close A 20-year contract recently awarded to OraVax (now Acambis Inc, Cambridge, MA, USA) for large-scale production of smallpox vaccine for the US Centers for Disease Control...
doi:10.1016/S0140-6736(06)68420-1
...collaboration. *Michel Warny, Jacques Pepin, Aiqi Fang, George Killgore, L Clifford McDonald michel.warny@acambis.com Acambis, 38 Sidney Street, Cambridge, MA 02139, USA (MW, AF); University of Sherbrooke, Sherbrooke, Quebec...
doi:10.1016/S1473-3099(02)00378-X
...in the light of increased stocks of VIG. By this time next year, the USA should have licensed sufficient stocks of the new Acambis smallpox vaccine to immunise everyone in the country. Because this vaccine is grown in tissue culture, it should be safer...
News and Blogs
Total : 29 View more »
'Report Predicts Chinese Pharma Market Will Reach $116.8bn in 2015' Says visiongain Report |
...China is Set to be the Most Important Pharmaceutical Market, Despite Weaknesses Companies Listed Abbott Laboratories Acambis Agilent Technologies American California Pharmaceutical Group Anhui BBCA Biochemical AppTech Laboratory Services...
Agenus' CEO Discusses Q2 2011 Results - Earnings Call Transcript - Seeking Alpha
...regarding sanofi pasteur. Number one, they took the Acambis 4 over from Acambis. I was wondering, I haven’t seen anything where...no longer being developed. So with the merger of Acambis and/or acquisition of Acambis with Sanofi, they...
HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
...methods and the approval process. In addition, the report focuses on the emerging vaccine activities of the following companies Acambis plc, ACE BioSciences, AFFiRiS, ALK-Abello A/S, Allergy Therapeutics, Bavarian Nordic A/S, Baxter Healthcare...
News: Acambis and Sanofi Pasteur to Further West Nile Virus Vaccine in Deal Worth over $80M.
... Nov 13 2007, 12:20 PM EST Acambis and Sanofi Pasteur to Further West Nile...a deal related to development and marketing of Acambis’ ChimeriVax™-West Nile vaccine. Acambis stands to earn over $80 million in this...
